The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety of radiotherapy with concurrent and adjuvant MEDI4736 (durvalumab) in patients with locoregionally advanced head and neck cancer with a contraindication to cisplatin: NRG-HN004.
 
Loren K. Mell
Honoraria - Nanobiotix; Varian Medical Systems
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Pedro A. Torres-Saavedra
No Relationships to Disclose
 
Stuart J. Wong
Research Funding - Merck; Novartis
 
Steven Chang
No Relationships to Disclose
 
Julie Ann Kish
No Relationships to Disclose
 
Andy Minn
No Relationships to Disclose
 
Richard C. Jordan
Stock and Other Ownership Interests - Genomic Health
 
Tian Liu
No Relationships to Disclose
 
Minh Tam Truong
No Relationships to Disclose
 
Julie E. Bauman
Consulting or Advisory Role - AstraZeneca/MedImmune; CUE Biopharma; Merck Serono
Research Funding - AVEO (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Moderna Therapeutics (Inst); Novartis (Inst)
 
Steven Francis Powell
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Vyriad (Inst)
 
Abderrahim Khomani
No Relationships to Disclose
 
Muhammad Kashif Riaz
No Relationships to Disclose
 
David Raben
Honoraria - AstraZeneca; BiolineRx
Consulting or Advisory Role - AstraZeneca; Genentech; Merck; Nanobiotix
Travel, Accommodations, Expenses - Nanobiotix
 
Quynh-Thu Le
Stock and Other Ownership Interests - Aldea
Consulting or Advisory Role - GRAIL
Travel, Accommodations, Expenses - Genentech